Sean Hua Lim

University of Southampton

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (12)

Benjamin H. Mullish

UNITED KINGDOM

View details

Daniel Rea

Professor of Medical Oncology

University of Birmingham

UNITED KINGDOM

View details

Hayley Colton

University of Sheffield

UNITED KINGDOM

View details

Donal Skelly

Academic Clinical Lecturer

University of Oxford

UNITED KINGDOM

View details

Peter Lanyon

Honorary Professor

University of Nottingham

UNITED KINGDOM

View details

Stefan Siebert

Professor of Inflammation Medicine and Rheumatology

University of Glasgow

UNITED KINGDOM

View details

Barbara Kronsteiner-Dobramysl

University of Oxford

UNITED KINGDOM

View details

Mark Cragg

Prof. at Faculty of Engineering and Physical Sciences

University of Southampton

UNITED KINGDOM

View details

Stephen P. McAdoo

Imperial College London

UNITED KINGDOM

View details

Joseph Chilcot

King’s College London

UNITED KINGDOM

View details

Anthony Brown

University of Oxford

UNITED KINGDOM

View details

Eleanor Barnes

Professor of Hepatology and Experimental Medicine

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sean Hua Lim

Research Interests

Explore related searches

Contact this professor

Articles (10)

Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study

Greater preservation of SARS‐CoV‐2 neutralising antibody responses following the ChAdOx1‐S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients

Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY

Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate

Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing

Two approaches to tackling COVID-19 in patients with blood cancer

COVID-19 infection in primary central nervous system lymphoma treatment: Who is most at risk?

Collaborators (12)

Benjamin H. Mullish

Daniel Rea

Hayley Colton

Donal Skelly

Peter Lanyon

Stefan Siebert

Barbara Kronsteiner-Dobramysl

Mark Cragg

Stephen P. McAdoo

Joseph Chilcot

Anthony Brown

Eleanor Barnes

Make your next move.